Sunday 1 November 2026
Export KDP’s income statement to Excel — free account
Keurig Dr Pepper, Inc
KDP Consumer Defensive Beverages Non Alcoholic
Keurig Dr Pepper, Inc’s revenue for fiscal 2025 (year ended December 2025) was $16.6 billion, up 8.16% from fiscal 2024.
- Revenue
- +75.6%
- EPS
- −90.0%
- Free cash flow
- +120.4%
- Total debt
- +115.4%
Quarter to June 2026, against a year earlier
35.84
0.54
+1.53%
Follow KDP
Alert me
Keurig Dr Pepper, Inc (KDP) SEC filings, changes and red flags
Red flags
-
Officer departure
Keurig Dr Pepper, Inc reported the departure of an officer or director
-
Inventory outpacing revenue
Inventory grew 121.5% while revenue grew 75.6% year over year
-
Impairment
Keurig Dr Pepper, Inc recorded a goodwill impairment of $306.0 million in fiscal 2024
Filings
| Form | Period | Filed | What it reports | Flags |
|---|---|---|---|---|
| 8-K | Oct 1, 2026 | 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 8-K | Sep 28, 2026 | 8.01 Other events | ||
| 8-K | Sep 16, 2026 | 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 8-K | Aug 28, 2026 | 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 8-K | Aug 10, 2026 | 5.02 Departure or appointment of directors or officers | Officer departure | |
| 10-Q | Jun 30, 2026 |
P1I2: 47 added · 9 removed · 25 modified P2I1A: no comparison — the earlier filing's Item cannot be compared |
Inventory outpacing revenue | |
| 8-K | Aug 6, 2026 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Jun 22, 2026 | 5.02 Departure or appointment of directors or officers | ||
| 8-K | Jun 23, 2026 | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 8-K | Jun 16, 2026 | 5.07 Submission of matters to a vote of security holders; 8.01 Other events | ||
| 8-K/A | Mar 30, 2026 | 9.01 Financial statements and exhibits | ||
| 8-K | May 21, 2026 | 8.01 Other events | ||
| 8-K | May 20, 2026 | 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 10-Q | Mar 31, 2026 | |||
| 8-K | Apr 23, 2026 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Mar 30, 2026 | 1.01 Entry into a material definitive agreement; 1.02 Termination of a material definitive agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sales of equity securities; 5.03 Amendments to the articles or bylaws; change in fiscal year; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 8-K | Mar 26, 2026 | 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits | ||
| 8-K | Mar 12, 2026 | 8.01 Other events | ||
| 8-K | Mar 6, 2026 | 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 10-K | Dec 31, 2025 |
1: 5 added · 6 removed · 24 modified 1A: 116 added · 6 removed · 40 modified 7: 15 added · 25 removed · 39 modified |
||
| 8-K | Feb 24, 2026 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Feb 23, 2026 | 1.01 Entry into a material definitive agreement; 3.02 Unregistered sales of equity securities; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 8-K | Feb 12, 2026 | 5.02 Departure or appointment of directors or officers; 8.01 Other events | ||
| 8-K | Feb 3, 2026 | 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 8-K | Dec 18, 2025 | 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits | ||
| 8-K | Dec 9, 2025 | 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 8-K | Nov 21, 2025 | 5.02 Departure or appointment of directors or officers | ||
| 8-K | Nov 21, 2025 | 8.01 Other events | ||
| 8-K | Oct 26, 2025 | 1.01 Entry into a material definitive agreement; 3.02 Unregistered sales of equity securities; 9.01 Financial statements and exhibits | ||
| 10-Q | Sep 30, 2025 | |||
| 8-K | Oct 27, 2025 | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 8-K | Oct 27, 2025 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Aug 26, 2025 | 8.01 Other events | ||
| 8-K | Sep 16, 2025 | 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 8-K | Aug 24, 2025 | 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 10-Q | Jun 30, 2025 | |||
| 8-K | Jul 24, 2025 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-Q | Mar 31, 2025 | |||
| 8-K | Apr 24, 2025 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-K | Dec 31, 2024 | Impairment | ||
| 8-K | Feb 25, 2025 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-Q | Sep 30, 2024 | |||
| 8-K | Oct 24, 2024 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-Q | Jun 30, 2024 | |||
| 8-K | Jul 25, 2024 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Apr 25, 2024 | 2.02 Results of operations and financial condition; 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits | ||
| 8-K | Feb 22, 2024 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits |